Cargando…

PB2363: R-MPV FOLLOWED BY CONSOLIDATION REDUCED-DOSE WHOLE-BRAIN RADIOTHERAPY AND CYTARABINE IN NEWLY DIAGNOSED PRIMARY CNS LYMPHOMA: REAL WORLD DATA

Detalles Bibliográficos
Autores principales: Amani, Maha EL, Haidouri, Soukaina, Afodome, Apolinaire, Doghmi, Othman, Hari, Oumayma, Aghoutane, Yossra, Benlachgar, Naoufal, Bououad, Majdouline, Mezalek, Zoubida Tazi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10429141/
http://dx.doi.org/10.1097/01.HS9.0000976168.82513.54
_version_ 1785090636799541248
author Amani, Maha EL
Haidouri, Soukaina
Afodome, Apolinaire
Doghmi, Othman
Hari, Oumayma
Aghoutane, Yossra
Benlachgar, Naoufal
Bououad, Majdouline
Mezalek, Zoubida Tazi
author_facet Amani, Maha EL
Haidouri, Soukaina
Afodome, Apolinaire
Doghmi, Othman
Hari, Oumayma
Aghoutane, Yossra
Benlachgar, Naoufal
Bououad, Majdouline
Mezalek, Zoubida Tazi
author_sort Amani, Maha EL
collection PubMed
description
format Online
Article
Text
id pubmed-10429141
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-104291412023-08-17 PB2363: R-MPV FOLLOWED BY CONSOLIDATION REDUCED-DOSE WHOLE-BRAIN RADIOTHERAPY AND CYTARABINE IN NEWLY DIAGNOSED PRIMARY CNS LYMPHOMA: REAL WORLD DATA Amani, Maha EL Haidouri, Soukaina Afodome, Apolinaire Doghmi, Othman Hari, Oumayma Aghoutane, Yossra Benlachgar, Naoufal Bououad, Majdouline Mezalek, Zoubida Tazi Hemasphere Publication Only Lippincott Williams & Wilkins 2023-08-08 /pmc/articles/PMC10429141/ http://dx.doi.org/10.1097/01.HS9.0000976168.82513.54 Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially.
spellingShingle Publication Only
Amani, Maha EL
Haidouri, Soukaina
Afodome, Apolinaire
Doghmi, Othman
Hari, Oumayma
Aghoutane, Yossra
Benlachgar, Naoufal
Bououad, Majdouline
Mezalek, Zoubida Tazi
PB2363: R-MPV FOLLOWED BY CONSOLIDATION REDUCED-DOSE WHOLE-BRAIN RADIOTHERAPY AND CYTARABINE IN NEWLY DIAGNOSED PRIMARY CNS LYMPHOMA: REAL WORLD DATA
title PB2363: R-MPV FOLLOWED BY CONSOLIDATION REDUCED-DOSE WHOLE-BRAIN RADIOTHERAPY AND CYTARABINE IN NEWLY DIAGNOSED PRIMARY CNS LYMPHOMA: REAL WORLD DATA
title_full PB2363: R-MPV FOLLOWED BY CONSOLIDATION REDUCED-DOSE WHOLE-BRAIN RADIOTHERAPY AND CYTARABINE IN NEWLY DIAGNOSED PRIMARY CNS LYMPHOMA: REAL WORLD DATA
title_fullStr PB2363: R-MPV FOLLOWED BY CONSOLIDATION REDUCED-DOSE WHOLE-BRAIN RADIOTHERAPY AND CYTARABINE IN NEWLY DIAGNOSED PRIMARY CNS LYMPHOMA: REAL WORLD DATA
title_full_unstemmed PB2363: R-MPV FOLLOWED BY CONSOLIDATION REDUCED-DOSE WHOLE-BRAIN RADIOTHERAPY AND CYTARABINE IN NEWLY DIAGNOSED PRIMARY CNS LYMPHOMA: REAL WORLD DATA
title_short PB2363: R-MPV FOLLOWED BY CONSOLIDATION REDUCED-DOSE WHOLE-BRAIN RADIOTHERAPY AND CYTARABINE IN NEWLY DIAGNOSED PRIMARY CNS LYMPHOMA: REAL WORLD DATA
title_sort pb2363: r-mpv followed by consolidation reduced-dose whole-brain radiotherapy and cytarabine in newly diagnosed primary cns lymphoma: real world data
topic Publication Only
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10429141/
http://dx.doi.org/10.1097/01.HS9.0000976168.82513.54
work_keys_str_mv AT amanimahael pb2363rmpvfollowedbyconsolidationreduceddosewholebrainradiotherapyandcytarabineinnewlydiagnosedprimarycnslymphomarealworlddata
AT haidourisoukaina pb2363rmpvfollowedbyconsolidationreduceddosewholebrainradiotherapyandcytarabineinnewlydiagnosedprimarycnslymphomarealworlddata
AT afodomeapolinaire pb2363rmpvfollowedbyconsolidationreduceddosewholebrainradiotherapyandcytarabineinnewlydiagnosedprimarycnslymphomarealworlddata
AT doghmiothman pb2363rmpvfollowedbyconsolidationreduceddosewholebrainradiotherapyandcytarabineinnewlydiagnosedprimarycnslymphomarealworlddata
AT harioumayma pb2363rmpvfollowedbyconsolidationreduceddosewholebrainradiotherapyandcytarabineinnewlydiagnosedprimarycnslymphomarealworlddata
AT aghoutaneyossra pb2363rmpvfollowedbyconsolidationreduceddosewholebrainradiotherapyandcytarabineinnewlydiagnosedprimarycnslymphomarealworlddata
AT benlachgarnaoufal pb2363rmpvfollowedbyconsolidationreduceddosewholebrainradiotherapyandcytarabineinnewlydiagnosedprimarycnslymphomarealworlddata
AT bououadmajdouline pb2363rmpvfollowedbyconsolidationreduceddosewholebrainradiotherapyandcytarabineinnewlydiagnosedprimarycnslymphomarealworlddata
AT mezalekzoubidatazi pb2363rmpvfollowedbyconsolidationreduceddosewholebrainradiotherapyandcytarabineinnewlydiagnosedprimarycnslymphomarealworlddata